- Home
- ISRG vs ABT Comparison
ISRG vs ABT Comparison
Compare ISRG & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISRG | ABT |
|---|---|---|
| Founded | 1995 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 143.1B | 152.9B |
| IPO Year | 1998 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ISRG | ABT |
|---|---|---|
| Price | $400.95 | $96.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 32 | 27 |
| Target Price | ★ $476.34 | $120.26 |
| AVG Volume (30 Days) | 2.1M | ★ 5.5M |
| Earning Date | 10-20-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | ★ 22.59 | N/A |
| EPS | ★ 4.57 | 0.61 |
| Revenue | $10,064,700,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $16.81 | $13.26 |
| Revenue Next Year | $12.79 | $8.61 |
| P/E Ratio | ★ $89.01 | $165.49 |
| Revenue Growth | ★ 20.51 | 5.67 |
| 52 Week Low | $328.57 | $81.97 |
| 52 Week High | $603.88 | $135.37 |
Technical Indicators
Market Signals| Indicator | ISRG | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 63.77 | 31.36 |
| Support Level | $397.10 | $87.36 |
| Resistance Level | $446.92 | $104.19 |
| Average True Range (ATR) | 9.22 | 1.71 |
| MACD | 2.83 | -0.39 |
| Stochastic Oscillator | 85.60 | 6.00 |
Price Performance
Historical ComparisonAbout ISRG Intuitive Surgical Inc.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 11,000 da Vinci systems in hospitals worldwide, with more than 6,600 installations in the US and a growing number in emerging markets.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.